News
Four new articles from the NIH Technology Transfer Community have been published in the most recent edition of les Nouvelles, the Licensing Executive Society’s journal. NIH is not just a funder of science but is a critical catalyst that helps transform bold ideas into treatments that reach patients
Researchers at the NIH Clinical Center developed a new fungal-specific imaging ligand that exploits fungal-specific metabolic pathways absent in mammalian cells or bacteria to rapidly diagnose a live fungal infection in any patient and are seeking a collaborator to further develop this technology
World Intellectual Property (IP) Day is April 25th. This is a global event dedicated to industry inventors, creators, and entrepreneurs and how they achieve their goals through the use of IP. To celebrate, the Licensing Executives Society (LES) is hosting a free webinar to bring people together
In just eight years, the NIH National Institute of Allergy and Infectious Diseases moved from identifying an ultra-rare genetic disorder, CD55 deficiency, hyperactivation of the complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE) to FDA approval of its first treatment option